Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600 036, Tamil Nadu, India.
Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600 036, Tamil Nadu, India.
Biochem Biophys Res Commun. 2021 Apr 9;548:143-147. doi: 10.1016/j.bbrc.2021.02.060. Epub 2021 Feb 25.
Pannexin 1 (Panx1) has been implicated in a plethora of physiological and pathophysiological processes. It is one of the major ATP release channels in many cell types. Extracellular ATP, activates purinergic P2X and P2Y receptors, triggering several signaling cascades. A disease-associated mutation, Arg-217-His (R217H) in the 3rd transmembrane domain of Panx1 attenuates channel functions through an unknown mechanism. Since carboxyl terminus (CT) gates the channel, we hypothesized that R217 interacts with the CT, and this interaction is required for optimum channel activities. R217H mutation though reduced the currents in the full-length channel, did not affect CT-truncated Panx1-Δ386. Also, compared to the wild-type, Panx1-R217H expressing cells showed lesser cell death when activated through P2X7 receptor. However, cell death in Panx1-R217H-Δ386 and Panx1-Δ386 expressing cells were similar. The mutation is ineffective unless the channel has an intact CT. Based on our results we propose that R217H mutation perturbs the conformational flexibility of CT, leading to channel dysfunction.
连接蛋白 1(Panx1)参与了许多生理和病理生理过程。它是许多细胞类型中主要的 ATP 释放通道之一。细胞外 ATP 通过激活嘌呤能 P2X 和 P2Y 受体,触发多种信号级联反应。在 Panx1 的第 3 跨膜域中,与疾病相关的突变 Arg-217-His(R217H)通过未知机制减弱了通道功能。由于羧基末端(CT)控制着通道,我们假设 R217 与 CT 相互作用,这种相互作用是最佳通道活性所必需的。尽管 R217H 突变减少了全长通道中的电流,但它并不影响 CT 截断的 Panx1-Δ386。此外,与野生型相比,通过 P2X7 受体激活时,表达 Panx1-R217H 的细胞死亡较少。然而,表达 Panx1-R217H-Δ386 和 Panx1-Δ386 的细胞的死亡情况相似。除非通道具有完整的 CT,否则该突变无效。基于我们的结果,我们提出 R217H 突变会破坏 CT 的构象灵活性,导致通道功能障碍。